Multiple strains could be eliminated by the anti-FITC CAR T cells via lysis offering an universal treatment solution for the diverse nature of RA with limited toxicity.DR1 CAR T cells only target CII-specific CD4+ T cells and reduce the autoimmune T cell response and the severity of RA. The gene discussed is DR1; the disease is rheumatoid arthritis.